Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
INR 154.9
(1.6%)
INR 154.9
(1.6%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.32 Billion INR | 10.4% |
| 2022 | 3.01 Billion INR | 8.24% |
| 2021 | 2.78 Billion INR | -9.43% |
| 2020 | 3.07 Billion INR | 9.81% |
| 2019 | 2.79 Billion INR | 21.4% |
| 2018 | 2.3 Billion INR | 20.31% |
| 2017 | 1.91 Billion INR | 12.91% |
| 2016 | 1.69 Billion INR | 4.7% |
| 2015 | 1.62 Billion INR | -12.53% |
| 2014 | 1.85 Billion INR | -2.16% |
| 2013 | 1.89 Billion INR | 37.56% |
| 2012 | 1.37 Billion INR | 11.13% |
| 2011 | 1.23 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.43 Billion INR | 466.65% |
| 2024 Q2 | 321.92 Million INR | -86.8% |
| 2023 Q1 | 2.35 Billion INR | 423.83% |
| 2023 FY | 3.32 Billion INR | 10.4% |
| 2023 Q3 | 317.37 Million INR | 40.63% |
| 2023 Q2 | 225.67 Million INR | -90.41% |
| 2023 Q4 | 430.38 Million INR | 35.61% |
| 2022 Q4 | 449.15 Million INR | 77.55% |
| 2022 Q2 | 217.28 Million INR | -89.62% |
| 2022 FY | 3.01 Billion INR | 8.24% |
| 2022 Q1 | 2.09 Billion INR | 669.39% |
| 2022 Q3 | 252.97 Million INR | 16.42% |
| 2021 Q1 | 2.14 Billion INR | 291.68% |
| 2021 Q4 | 272.1 Million INR | 25.64% |
| 2021 FY | 2.78 Billion INR | -9.43% |
| 2021 Q3 | 216.57 Million INR | 45.78% |
| 2021 Q2 | 148.56 Million INR | -93.08% |
| 2020 FY | 3.07 Billion INR | 9.81% |
| 2020 Q4 | 547.99 Million INR | 52.09% |
| 2020 Q1 | 1.93 Billion INR | 221.3% |
| 2020 Q2 | 232.63 Million INR | -87.96% |
| 2020 Q3 | 360.3 Million INR | 54.88% |
| 2019 Q4 | 601.45 Million INR | 81.94% |
| 2019 Q3 | 330.57 Million INR | 54.73% |
| 2019 FY | 2.79 Billion INR | 21.4% |
| 2019 Q1 | 1.65 Billion INR | 218.32% |
| 2019 Q2 | 213.64 Million INR | -87.08% |
| 2018 Q3 | 278.77 Million INR | 17.23% |
| 2018 Q4 | 519.35 Million INR | 86.3% |
| 2018 FY | 2.3 Billion INR | 20.31% |
| 2018 Q1 | 1.26 Billion INR | 153.86% |
| 2018 Q2 | 237.8 Million INR | -81.27% |
| 2017 Q4 | 500.11 Million INR | 94.21% |
| 2017 FY | 1.91 Billion INR | 12.91% |
| 2017 Q1 | 1.01 Billion INR | 99.92% |
| 2017 Q2 | 143.91 Million INR | -85.82% |
| 2017 Q3 | 257.51 Million INR | 78.93% |
| 2016 Q1 | 843.29 Million INR | 198.06% |
| 2016 Q3 | 181.72 Million INR | 10.45% |
| 2016 Q4 | 507.69 Million INR | 179.37% |
| 2016 Q2 | 164.53 Million INR | -80.49% |
| 2016 FY | 1.69 Billion INR | 4.7% |
| 2015 Q3 | 233.17 Million INR | 490.37% |
| 2015 Q4 | 282.93 Million INR | 21.34% |
| 2015 Q2 | 39.49 Million INR | -96.29% |
| 2015 Q1 | 1.06 Billion INR | 1026.06% |
| 2015 FY | 1.62 Billion INR | -12.53% |
| 2014 FY | 1.85 Billion INR | -2.16% |
| 2014 Q4 | 94.61 Million INR | -64.07% |
| 2014 Q3 | 263.32 Million INR | -12.41% |
| 2014 Q2 | 300.62 Million INR | -74.84% |
| 2014 Q1 | 1.19 Billion INR | 195.96% |
| 2013 Q4 | 403.66 Million INR | 53.87% |
| 2013 FY | 1.89 Billion INR | 37.56% |
| 2013 Q1 | 1.03 Billion INR | 344.49% |
| 2013 Q2 | 194.97 Million INR | -81.13% |
| 2013 Q3 | 262.35 Million INR | 34.56% |
| 2012 Q1 | 827.19 Million INR | 0.0% |
| 2012 Q3 | 143.01 Million INR | -17.99% |
| 2012 Q4 | 232.44 Million INR | 62.54% |
| 2012 Q2 | 174.37 Million INR | -78.92% |
| 2012 FY | 1.37 Billion INR | 11.13% |
| 2011 FY | 1.23 Billion INR | 0.0% |